Cbl-b-IN-1 (example 519 presented in the referenced in patent WO2019148005A1) is a novel and potent Cbl-b inhibitor, with an IC50<100 nM. References:INHIBITORS OF CBL-B AND METHODS OF USE THEREOF. WO/2019/148005A1.
Cbl-b-IN-1 (example 519 presented in the referenced in patent WO2019148005A1) is a novel and potent Cbl-b inhibitor, with an IC50<100 nM.
References:INHIBITORS OF CBL-B AND METHODS OF USE THEREOF. WO/2019/148005A1.
纯度：≥98%
CAS：2368841-84-1
m.cnreagent.com
